Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DCTN3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP5O - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DNAJC19 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NEDD8 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP5L - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NDUFAB1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COX5A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COPS8 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COX6A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP5J - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
C3orf14 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MKRN2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MOCS2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CEP68 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COX6B1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DYNC2LI1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PSMD2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SERF1B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on